Management of hepatocellular carcinoma during the COVID-19 pandemic - Sao Paulo clinicas liver cancer group multidisciplinary consensus statement (2020)
- Authors:
- USP affiliated authors: ABDALA, EDSON - FM ; D'ALBUQUERQUE, Luiz Augusto Carneiro - FM ; HERMAN, Paulo - FM ; CARRILHO, Flair Jose - FM
- Unidade: FM
- DOI: 10.6061/clinics/2020/e2192
- Subjects: COVID-19; CARCINOMA HEPATOCELULAR; CONSENSO; INFECÇÕES POR CORONAVIRUS; NEOPLASIAS HEPÁTICAS
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
CHAGAS, Aline Lopes et al. Management of hepatocellular carcinoma during the COVID-19 pandemic - Sao Paulo clinicas liver cancer group multidisciplinary consensus statement. Clinics, v. 75, 2020Tradução . . Disponível em: https://doi.org/10.6061/clinics/2020/e2192. Acesso em: 28 dez. 2025. -
APA
Chagas, A. L., Fonseca, L. G., Coelho, F. F., Saud, L. R. C., Abdala, E., Andraus, W., et al. (2020). Management of hepatocellular carcinoma during the COVID-19 pandemic - Sao Paulo clinicas liver cancer group multidisciplinary consensus statement. Clinics, 75. doi:10.6061/clinics/2020/e2192 -
NLM
Chagas AL, Fonseca LG, Coelho FF, Saud LRC, Abdala E, Andraus W, Fiore L, D'albuquerque LAC, Herman P, Carrilho FJ. Management of hepatocellular carcinoma during the COVID-19 pandemic - Sao Paulo clinicas liver cancer group multidisciplinary consensus statement [Internet]. Clinics. 2020 ; 75[citado 2025 dez. 28 ] Available from: https://doi.org/10.6061/clinics/2020/e2192 -
Vancouver
Chagas AL, Fonseca LG, Coelho FF, Saud LRC, Abdala E, Andraus W, Fiore L, D'albuquerque LAC, Herman P, Carrilho FJ. Management of hepatocellular carcinoma during the COVID-19 pandemic - Sao Paulo clinicas liver cancer group multidisciplinary consensus statement [Internet]. Clinics. 2020 ; 75[citado 2025 dez. 28 ] Available from: https://doi.org/10.6061/clinics/2020/e2192 - Efficacy of -Lactam/-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum--LactamaseProducing Enterobacteriaceae in Hematological Patients with Neutropenia C
- Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospective observational study (BICAR)
- Clinical profile and mortality predictors for tuberculosis disease among patients with solid tumours
- Profilaxia de infecções pós-transplante
- Development of a risk prediction model for carbapenem-resistant enterobacteriaceae infection after liver transplantation: a multinational cohort study
- Contribuição científica para o manejo das infecções em transplantes de órgãos sólidos
- Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study
- Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study
- Thermal and chronological stability of monocyte distribution width (MDW), the new biomarker for sepsis. [Carta]
- Endemic Fungal Infection Recommendations for Solid-Organ Transplant Recipients and Donors
Informações sobre o DOI: 10.6061/clinics/2020/e2192 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
